SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical (DRTS) is generating significant discussion after presenting compelling data on its Alpha DaRT study, which demonstrated an 81% disease control rate in advanced pancreatic cancer at a recent major healthcare conference. The community is eagerly anticipating potential regulatory approval in Japan and closely following its expanding pipeline of U.S. clinical trials, while rumors of prominent institutional interest further elevate its profile as a revolutionary cancer treatment.

The ticket is $Testicle. EVERY SINGLE ONE OF YOU CAME FROM A $Testicle. $Testicle always bounce.   We have a website on which you can create art or memes. We have a community. We have a raid group. We aim to provide the best testicular care on CT.   We might even have to call on our nefarious leader, Harry Bolz. Alright Chad, SACK TF. Or else you’re a Low T beta male.   If you have questions and or concerns please feel to reach out to a team member on how you can acquire or become a high testosterone male in a sea of betas. I mean how else does one live if not as a High T male?

Testicle

TESTICLE CRYPTO is trending due to its outrageous name and perceived meme coin status, sparking a divided but highly engaged community discussion. Investors are either "all-in" for what they jokingly or seriously call a "generational hold," or outright dismissing it as a joke and a symptom of a "broken" market. The token's notoriety is amplified by its association with similarly named cryptocurrencies like $BALLSACK, fueling conversations around speculative investments in the current market environment.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as its Plaquemines LNG facility demonstrates increasing operational efficiency through rising cargo exports and approved capacity expansion without new capital expenditure. The community is actively discussing favorable natural gas price spreads and high short interest, alongside ongoing anticipation for resolutions in its legal disputes.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox (BW) is attracting significant attention as investors anticipate the imminent finalization of a transformative $1.5 billion contract with Applied Digital (APLD). This pivotal deal, centered on providing 1 GW of natural gas power for a new AI data center, is widely viewed by the community as a game-changer, establishing BW as a crucial and rapidly deployable energy solution for the booming AI infrastructure.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following the landmark FDA approval of REDEMPLO (plozasiran) for familial chylomicronemia syndrome, a pivotal milestone that establishes the company as a commercial-stage entity. This achievement is sparking strong community enthusiasm, with discussions highlighting REDEMPLO's market-leading potential and its role in de-risking a deep RNAi pipeline that includes highly anticipated obesity drug data and a groundbreaking CNS delivery platform. Many investors feel the market has yet to fully appreciate these platform capabilities, suggesting the stock remains significantly undervalued despite recent analyst price target adjustments.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing significant market attention, primarily driven by strong community speculation about a potential short squeeze, given its notably high short interest and institutional accumulation, particularly by Pale Fire Capital. Bulls highlight strategic business developments, including a recent health deal and the hidden value of its SumUp stake, as signs of a turnaround. However, many skeptics fiercely debate its fundamental valuation, attributing recent price movements to manipulation rather than sustained growth.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending high following significant regulatory approval for its ANKTIVA therapy in Saudi Arabia for both bladder and lung cancers, which is seen by many as a pivotal de-risking event. This catalyst, coupled with robust preliminary revenue growth and the CEO's active engagement, is sparking widespread community discussions about a potential short squeeze and a transformative shift in cancer treatment paradigms.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending due to a high-profile lawsuit threat from Donald Trump and his proposal to cap credit card interest rates, sparking intense debate about regulatory impacts on the financial sector. This political pressure compounds mixed reactions to JPM's recent quarterly earnings, where a stock dip occurred despite a beat, largely attributed to an Apple Card reserve, prompting community discussions on market resilience and potential banking profitability shifts.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending due to significant agreements, including a $2.65 billion fuel cell purchase pact with American Electric Power and a $502 million deal with Quanta, underscoring its pivotal role in addressing the escalating power demands of AI data centers. The community is buzzing with excitement over these substantial contracts and the company's rapid deployment solutions, while some also express caution regarding its swift valuation increase.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X Shares

Direxion Daily TSLA Bull 2X Shares

TSLL is trending due to significant volatility, recently impacted by a notable dividend distribution that caused a sharp price drop and options market disruption, fueling intense debate among traders. The community is sharply divided, with many buying the dip on its underlying asset, TSLA, driven by optimism around AI and robotics, while others remain bearish, citing valuation concerns and the leveraged ETF's inherent decay.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETFs to Consider Amid Geopolitical Woes and Higher US Military Budget 

Trump's $1.5T military budget and rising global tensions could lift defense ETFs and spill over into cybersecurity, AI, manufacturing and space ETFs.

Invest in Tomorrow's Space Economy With These ETFs

The space economy is taking off as innovation, SpaceX IPO buzz and Moon missions fuel sector growth. Here are ETFs to ride the sector's rapid growth and momentum.

Space ETFs Poised to Boost Your Portfolio Gains

The S&P Kensho Space Index's stellar rally, fueled by record $3.5B in global funding, signals booming investor confidence in the space economy.

Space Exploration ETF (ARKX) Hits New 52-Week High  

ARKX surges to a new 52-week high, soaring nearly 97% from its low as space exploration investments fuel momentum.

Senator Ted Cruz reportedly said on Wednesday that it is imperative for the U.S. to win against China in the race for artificial intelligence, 6G, the Arctic, and getting back on the moon. “If they get to the moon before us, if they seize the prime strategic real estate on the moon, I think that moment would be worse than Sputnik,” he said during an&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=dK3taoZ57V0">interview</a> with CNBC while talking about his new bill to reduce regulatory burden facing AI companies. The proposal would require the federal government to create a contained and secure testing area for AI software, known as a regulatory sandbox.“The stakes are enormous,” he&nbsp;added, noting that China has a target to land its astronauts on the moon by 2030. “$9.5 billion in the One Big Beautiful Bill was allocated to fund a U.S. return to the moon.”He added that other provisions in the bill are designed to help the U.S. compete with China across multiple strategic areas. This includes deploying 800 MHz of spectrum for advanced communications and investing $24 billion in Arctic capabilities such as coast guard vessels and polar icebreakers, where he warned that China is currently outpacing the United States.The&nbsp;<a href="http://stocktwits.com/symbol/ITA">iShares US Aerospace and Defense ETF (ITA)</a> edged 0.76% higher in morning trade as the broader market also trended higher after the producer price index (PPI) report on Wednesday indicated that inflation may be contained, increasing optimism that the Federal Reserve may cut interest rates soon. However, retail sentiment around the ITA ETF dipped to ‘neutral’ from ‘bullish’ over the past day.Meanwhile, the&nbsp;<a href="https://stocktwits.com/symbol/ARKX">ARK Space Exploration and Innovation ETF (ARKX)</a> rose 0.82% in morning trade on Wednesday, but retail sentiment around the ETF dipped lower. Stocktwits data showed a shift to ‘bearish’ territory from ‘neutral’ over the past day.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/solana-hits-7-month-high-dogecoin-slips-despite-etf-buzz/chwkBQlRdu5">Solana Hits 7-Month High, Dogecoin Slips Despite ETF Buzz As Bitcoin Stalls Ahead Of PPI Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Sen. Ted Cruz (R-TX) leaves the Senate Chamber following a vote at the U.S. Capitol on August 01, 2025 in Washington, DC. (Photo by Chip Somodevilla/Getty Images)

Ted Cruz Says Losing Moon Race to China Would Be ‘Worse Than Sputnik’

The Senator stated that the U.S. needs to win against China on all fronts, which includes artificial intelligence, 6G, the Arctic, and getting back on the moon.

Equity

3 Reasons to Buy Space ETFs With a Long-Term View

With SpaceX's progress, fresh IPOs, and government support, the space sector is drawing investors' attention, with ETFs like UFO, ARKX, SPRX, and ROKT offering diversified exposure.

5 Sector ETFs Rallying on Q2 Earnings Strength

GAMR, ALAI, ARKX, PFI and ONLN shine as strong Q2 earnings lift sectors from gaming and AI to retail and aerospace.


Space IPOs Grabbing Attention: ETFs in Focus 

Aerospace IPOs are surging in 2025. ETF plays like UFO and ARKX drawing investor interest.

The Zacks Analyst Blog Highlights ARK Space Exploration & Innovation ETF, Spear Alpha ETF, Procure Space ETF and SPDR S&P Kensho Final Frontiers ETF

ARKX, SPRX, UFO and ROKT ride rising defense, tourism and climate demand as investor interest in space ETFs accelerates.

Space ETFs That Can Launch Your Portfolio Higher 

The S&P Kensho Space Index's 51.99% surge underscores investor enthusiasm as defense, tourism and climate tech fuel the booming space economy.

Current Price	$35.20
Prev Close	$34.59
Open	$34.93
Dividend Yield	N/A
50-Day Moving Average	$29.31
Beta	N/A
Avg. Volume	420,103.82
PE Ratio	N/A

52-Week High	$35.53
52-Week Low	$15.08
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

ARKX
ARK Space Exploration & Innovation ETF

Feed

News

Sentiment

Fundamentals

Info

Latest ARKX News

ARKXARK Space Exploration & Innovation ETF